TLR7/9 Antagonists as Therapeutics for Immune-Mediated Inflammatory Disorders

E-ISSN： 2212-4055|6|4|223-235

ISSN： 1871-5281

Source： Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol.6, Iss.4, 2007-12, pp. : 223-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pyrazolones as therapeutics for kinase-mediated inflammatory disorders

By Clark Michael P Bookland Roger G

Expert Opinion on Therapeutic Patents, Vol. 15, Iss. 11, 2005-11 ,pp. : 1617-1623

Informa Healthcare

Access to resources Recommend Favorite

Biologics in Inflammatory Immune-mediated Systemic Diseases

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 12, 2018-03 ,pp. : 1008-1016

Bentham Science Publishers

Access to resources Recommend Favorite

ITK Inhibitors in Inflammation and Immune-Mediated Disorders

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 8, 2009-05 ,pp. : 690-703

Bentham Science Publishers

Access to resources Recommend Favorite

The Protective Effects of Extra Virgin Olive Oil on Immune-mediated Inflammatory Responses

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 18, Iss. 1, 2017-12 ,pp. : 23-35

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial: The Biologic Era: A Comprehensive Approach for Inflammatory and Immune-mediated Diseases

Current Pharmaceutical Biotechnology, Vol. 18, Iss. 12, 2018-03 ,pp. : 944-944

Bentham Science Publishers

Access to resources Recommend Favorite